Cargando…
Heterogeneity of tumour mutational burden in metastatic NSCLC demonstrated by endobronchial ultrasound sampling
INTRODUCTION: Tumour mutational burden (TMB) is an important emerging biomarker for immune checkpoint inhibitors (ICI). The stability of TMB values across distinct EBUS tumour regions is not well defined in advanced lung cancer patients. METHODS: This study included a whole-genome sequencing cohort...
Autores principales: | Leong, Tracy L., Aloe, Christian, Aujla, Savreet, Wang, Hao, Gayevskiy, Velimir, Asselin-Labat, Marie-Liesse, Gray, Lesley-Ann, Steinfort, Daniel, Bozinovski, Steven |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10042177/ https://www.ncbi.nlm.nih.gov/pubmed/36994206 http://dx.doi.org/10.3389/fonc.2023.1150349 |
Ejemplares similares
-
Integrating endobronchial ultrasound bronchoscopy with molecular testing of immunotherapy biomarkers in non-small cell lung cancer
por: Bozinovski, Steven, et al.
Publicado: (2021) -
Methods for assessment of the tumour microenvironment and immune interactions in non-small cell lung cancer. A narrative review
por: Rangamuwa, Kanishka, et al.
Publicado: (2023) -
Thermal ablation in non-small cell lung cancer: a review of treatment modalities and the evidence for combination with immune checkpoint inhibitors
por: Rangamuwa, Kanishka, et al.
Publicado: (2021) -
Adult lung stem cells and their contribution to lung tumourigenesis
por: Asselin-Labat, Marie-Liesse, et al.
Publicado: (2012) -
Regulation of the antigen presentation machinery in cancer and its implication for immune surveillance
por: Balasubramanian, Adithya, et al.
Publicado: (2022)